Corticosteroids and tocilizumab reduce in-hospital mortality in severe COVID-19 pneumonia: a retrospective study in a Spanish hospital

BACKGROUND: There is an urgent need to reduce mortality of COVID-19. We examined if corticosteroids and tocilizumab reduce risk for death in patients with severe pneumonia caused by SARS-CoV-2. METHODS: A retrospective cohort study was performed in a single university hospital. All adult patients ad...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Infect Dis (Lond)
Hlavní autoři: Van den Eynde, E., Gasch, O., Oliva, J. C., Prieto, E., Calzado, S., Gomila, A., Machado, M. L., Falgueras, L., Ortonobes, S., Morón, A., Capilla, S., Navarro, G., Oristrell, J., Cervantes, M., Navarro, M.
Médium: Artigo
Jazyk:Inglês
Vydáno: Taylor & Francis 2021
Témata:
Original Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7919103/
https://ncbi.nlm.nih.gov/pubmed/33620019
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/23744235.2021.1884286
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky